Lantheus (0L8) Stock Forecast & Price Target

Compare

7 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0L8 Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Lantheus

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0L8 Stock 12 Month Forecast

Average Price Target

€76.76

▲(9.94% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Lantheus in the last 3 months. The average price target is €76.76 with a high forecast of €96.08 and a low forecast of €68.13. The average price target represents a 9.94% change from the last price of €69.82.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"41":"€41","55":"€55","69":"€69","83":"€83","97":"€97"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":96.0795187,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€96.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76.7588009396,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€76.76</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.12911326,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€68.13</span>\n  </div></div>","useHTML":true}}],"tickPositions":[41,55,69,83,97],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.8,68.12919374615385,70.4583874923077,72.78758123846154,75.11677498461538,77.44596873076922,79.77516247692307,82.10435622307692,84.43354996923077,86.7627437153846,89.09193746153846,91.4211312076923,93.75032495384615,{"y":96.0795187,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.8,66.64298468766154,67.48596937532308,68.32895406298461,69.17193875064615,70.01492343830769,70.85790812596923,71.70089281363076,72.5438775012923,73.38686218895384,74.22984687661538,75.07283156427691,75.91581625193845,{"y":76.7588009396,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.8,65.97916255846154,66.15832511692308,66.33748767538461,66.51665023384615,66.69581279230769,66.87497535076923,67.05413790923076,67.2333004676923,67.41246302615384,67.59162558461539,67.77078814307691,67.94995070153846,{"y":68.12911326,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":88.58,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.22,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.94,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.76,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.98,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.53,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.82,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.52,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.36,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€96.08

Average Price Target€76.76

Lowest Price Target€68.13

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matthew Taylor

Jefferies

€95.38

Buy

36.61%

Upside

Reiterated

03/18/26

Lantheus price target raised to $110 from $105 at JefferiesLantheus price target raised to $110 from $105 at Jefferies

Richard Newitter

Truist Financial

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Lantheus (NASDAQ: LNTH) and Monte Rosa Therapeutics (NASDAQ: GLUE)

Andy Hsieh

William Blair

€68.07

Buy

-2.51%

Downside

Assigned

03/17/26

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

Anthony Petrone

Mizuho Securities

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Lantheus (LNTH), Century Therapeutics (IPSC)

Tara Bancroft

TD Cowen

€65.03→€73.7

Buy

5.56%

Upside

Reiterated

02/26/26

Lantheus: Resilient Pylarify Performance and Cash Generation Underpin Buy Rating Despite Near‑Term Pricing Headwinds

Justin Walsh

JonesTrading

―

Hold

―

Downgraded

02/26/26

Lantheus downgraded to Hold from Buy at JonesResearchLantheus downgraded to Hold from Buy at JonesResearch

David Turkaly

Citizens JMP

€63.3→€67.63

Buy

-3.13%

Downside

Reiterated

02/24/26

Lantheus price target raised to $78 from $73 at CitizensLantheus price target raised to $78 from $73 at Citizens

Yuan Zhi

B. Riley Securities

€72.84

Buy

4.32%

Upside

Reiterated

10/30/25

Analysts Offer Insights on Healthcare Companies: Opko Health (NASDAQ: OPK) and Lantheus (NASDAQ: LNTH)

Paul Choi

Goldman Sachs

€95.38→€66.77

Hold

-4.37%

Downside

Downgraded

10/09/25

Lantheus Downgraded to Neutral Amid Pricing Pressures and Acquisition Uncertainty

Roanna Ruiz

Leerink Partners

€116.19→€85.84

Buy

22.95%

Upside

Reiterated

08/22/25

Leerink Partners Keeps Their Buy Rating on Lantheus (LNTH)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matthew Taylor

Jefferies

€95.38

Buy

36.61%

Upside

Reiterated

03/18/26

Lantheus price target raised to $110 from $105 at JefferiesLantheus price target raised to $110 from $105 at Jefferies

Richard Newitter

Truist Financial

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Lantheus (NASDAQ: LNTH) and Monte Rosa Therapeutics (NASDAQ: GLUE)

Andy Hsieh

William Blair

€68.07

Buy

-2.51%

Downside

Assigned

03/17/26

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

Anthony Petrone

Mizuho Securities

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Lantheus (LNTH), Century Therapeutics (IPSC)

Tara Bancroft

TD Cowen

€65.03→€73.7

Buy

5.56%

Upside

Reiterated

02/26/26

Lantheus: Resilient Pylarify Performance and Cash Generation Underpin Buy Rating Despite Near‑Term Pricing Headwinds

Justin Walsh

JonesTrading

―

Hold

―

Downgraded

02/26/26

Lantheus downgraded to Hold from Buy at JonesResearchLantheus downgraded to Hold from Buy at JonesResearch

David Turkaly

Citizens JMP

€63.3→€67.63

Buy

-3.13%

Downside

Reiterated

02/24/26

Lantheus price target raised to $78 from $73 at CitizensLantheus price target raised to $78 from $73 at Citizens

Yuan Zhi

B. Riley Securities

€72.84

Buy

4.32%

Upside

Reiterated

10/30/25

Analysts Offer Insights on Healthcare Companies: Opko Health (NASDAQ: OPK) and Lantheus (NASDAQ: LNTH)

Paul Choi

Goldman Sachs

€95.38→€66.77

Hold

-4.37%

Downside

Downgraded

10/09/25

Lantheus Downgraded to Neutral Amid Pricing Pressures and Acquisition Uncertainty

Roanna Ruiz

Leerink Partners

€116.19→€85.84

Buy

22.95%

Upside

Reiterated

08/22/25

Leerink Partners Keeps Their Buy Rating on Lantheus (LNTH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lantheus

3 Months

xxx

Success Rate

17/30 ratings generated profit

Average Return

+5.17%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.67% of your transactions generating a profit, with an average return of +5.17% per trade.

1 Year

Anthony PetroneMizuho Securities

Success Rate

14/24 ratings generated profit

Average Return

+16.84%

Copying Anthony Petrone's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +16.84% per trade.

2 Years

xxx

Success Rate

11/18 ratings generated profit

Average Return

+20.36%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 61.11% of your transactions generating a profit, with an average return of +20.36% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0L8 Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0L8 has received 13 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0L8 average Analyst price target in the past 3 months is 76.76.

Each month's total comprises the sum of three months' worth of ratings.

0L8 Financial Forecast

0L8 Earnings Forecast

Next quarter’s earnings estimate for 0L8 is €1.07 with a range of €0.94 to €1.16. The previous quarter’s EPS was €1.45. 0L8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.

0L8 Sales Forecast

Next quarter’s sales forecast for 0L8 is €308.24M with a range of €296.71M to €320.08M. The previous quarter’s sales results were €353.33M. 0L8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.

0L8 Stock Forecast FAQ

What is DE:0L8’s average 12-month price target, according to analysts?

Based on analyst ratings, Lantheus’s 12-month average price target is 76.76.

What is DE:0L8’s upside potential, based on the analysts’ average price target?

Lantheus has 9.94% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Lantheus a Buy, Sell or Hold?

Lantheus has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Lantheus’s share price target?

The average share price target for Lantheus is 76.76. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €96.08 ,and the lowest forecast is €68.13. The average share price target represents 9.94% Increase from the current price of €69.82.

What do analysts say about Lantheus?

Lantheus’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Lantheus?

To buy shares of DE:0L8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Lantheus (0L8) Stock Forecast & Price Target

0L8 Analyst Ratings

0L8 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Lantheus

0L8 Analyst Recommendation Trends

0L8 Financial Forecast

0L8 Earnings Forecast

0L8 Sales Forecast

0L8 Stock Forecast FAQ

Detailed List of Analyst Forecasts